STOCK TITAN

[Form 4] DaVita Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

DaVita Inc. director Gregory J. Moore acquired 369 shares of DaVita common stock on 08/15/2025 at no reported cash price (Code V). After the transaction he beneficially owned 6,820 shares, held directly. The Form 4 discloses this routine insider purchase; no derivative transactions or additional disclosures are reported in the filing.

Il direttore di DaVita Inc., Gregory J. Moore, ha acquistato 369 azioni ordinarie di DaVita il 15/08/2025 senza indicazione di prezzo in contanti (Codice V). Dopo l'operazione deteneva direttamente beneficiariamente 6.820 azioni. Il Modulo 4 segnala questo acquisto di routine da parte di un insider; nel deposito non sono riportate transazioni in derivati né altre comunicazioni aggiuntive.

El director de DaVita Inc., Gregory J. Moore, adquirió 369 acciones ordinarias de DaVita el 15/08/2025 sin que se informara un precio en efectivo (Código V). Tras la operación poseía beneficiosamente 6.820 acciones, mantenidas directamente. El Formulario 4 revela esta compra rutinaria por parte de un insider; en la presentación no se reportan transacciones con derivados ni divulgaciones adicionales.

DaVita Inc. 이사 Gregory J. Moore는 2025년 8월 15일에 DaVita 보통주 369주를 현금가 미보고(코드 V)로 취득했습니다. 거래 후 그는 직접 보유하는 형태로 총 6,820주를 실질적으로 보유하게 되었습니다. 제출된 Form 4는 내부자에 의한 통상적 매입을 공시하며, 파생상품 거래나 추가 공시는 보고되지 않았습니다.

Le directeur de DaVita Inc., Gregory J. Moore, a acquis 369 actions ordinaires de DaVita le 15/08/2025 sans prix en espèces déclaré (Code V). Après la transaction, il détenait bénéficiairement 6 820 actions, détenues directement. Le formulaire 4 divulgue cet achat courant par un initié ; aucune opération sur dérivés ni autre divulgation n'est signalée dans le dépôt.

Der Direktor von DaVita Inc., Gregory J. Moore, erwarb am 15.08.2025 369 Stammaktien von DaVita ohne angegebenen Barpreis (Code V). Nach der Transaktion besaß er wirtschaftlich 6.820 Aktien, die direkt gehalten werden. Das Formular 4 weist auf diesen routinemäßigen Insiderkauf hin; in der Einreichung sind keine Derivatgeschäfte oder weiteren Angaben vermerkt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A director purchased a small block of shares; disclosure is routine and non-material for most investors.

The filing shows a direct acquisition of 369 shares by a company director under Code V, indicating stock received upon exercise or vesting conditions rather than a market purchase with cash consideration. The post-transaction ownership of 6,820 shares is modest relative to a large-cap issuer. No derivative positions or material changes to control are indicated, so governance impact is minimal.

TL;DR: Insider acquisition disclosed, but size is unlikely to affect valuation or signal a material shift.

The reported transaction is small in absolute terms and priced at $0 per the form, consistent with issuance from an award or option exercise where price was previously paid or waived. There are no additional transactions or compensatory details that would materially alter outstanding share counts or investor assessment based on this filing alone.

Il direttore di DaVita Inc., Gregory J. Moore, ha acquistato 369 azioni ordinarie di DaVita il 15/08/2025 senza indicazione di prezzo in contanti (Codice V). Dopo l'operazione deteneva direttamente beneficiariamente 6.820 azioni. Il Modulo 4 segnala questo acquisto di routine da parte di un insider; nel deposito non sono riportate transazioni in derivati né altre comunicazioni aggiuntive.

El director de DaVita Inc., Gregory J. Moore, adquirió 369 acciones ordinarias de DaVita el 15/08/2025 sin que se informara un precio en efectivo (Código V). Tras la operación poseía beneficiosamente 6.820 acciones, mantenidas directamente. El Formulario 4 revela esta compra rutinaria por parte de un insider; en la presentación no se reportan transacciones con derivados ni divulgaciones adicionales.

DaVita Inc. 이사 Gregory J. Moore는 2025년 8월 15일에 DaVita 보통주 369주를 현금가 미보고(코드 V)로 취득했습니다. 거래 후 그는 직접 보유하는 형태로 총 6,820주를 실질적으로 보유하게 되었습니다. 제출된 Form 4는 내부자에 의한 통상적 매입을 공시하며, 파생상품 거래나 추가 공시는 보고되지 않았습니다.

Le directeur de DaVita Inc., Gregory J. Moore, a acquis 369 actions ordinaires de DaVita le 15/08/2025 sans prix en espèces déclaré (Code V). Après la transaction, il détenait bénéficiairement 6 820 actions, détenues directement. Le formulaire 4 divulgue cet achat courant par un initié ; aucune opération sur dérivés ni autre divulgation n'est signalée dans le dépôt.

Der Direktor von DaVita Inc., Gregory J. Moore, erwarb am 15.08.2025 369 Stammaktien von DaVita ohne angegebenen Barpreis (Code V). Nach der Transaktion besaß er wirtschaftlich 6.820 Aktien, die direkt gehalten werden. Das Formular 4 weist auf diesen routinemäßigen Insiderkauf hin; in der Einreichung sind keine Derivatgeschäfte oder weiteren Angaben vermerkt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Moore Gregory J.

(Last) (First) (Middle)
C/O DAVITA INC.
2000 16TH STREET

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 A 369 A $0 6,820 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Stephanie N. Berberich, Attorney-in-Fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Gregory J. Moore report on the Form 4 for DVA?

He reported acquiring 369 shares of DaVita common stock and beneficially owning 6,820 shares following the transaction.

When was the transaction reported on the Form 4 for DVA?

The transaction date shown is 08/15/2025 as the date of the acquisition.

Was the transaction in cash or another form on the DVA Form 4?

The form lists a price of $0 and uses Code V, consistent with stock received upon exercise, vesting, or similar non-cash issuance.

Does the Form 4 show any derivative securities or dispositions for DVA?

No. The filing contains only a non-derivative acquisition; Table II for derivative securities is empty.

Does the reported transaction change control of DaVita (DVA)?

No. The filing shows a modest insider holding of 6,820 shares and does not indicate any change in control.
Davita Inc

NYSE:DVA

DVA Rankings

DVA Latest News

DVA Latest SEC Filings

DVA Stock Data

9.77B
35.76M
49.99%
52.46%
8.24%
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States
DENVER